Validations: AI/ML Model Validation in GxP Analytics
AutoML/Model Marketplace Controls AutoML/Model Marketplace Controls In the evolving landscape of pharmaceutical research and development, the integration of Artificial Intelligence (AI) and Machine Learning (ML) has proven increasingly valuable. However, ensuring compliance with Good Manufacturing Practices (GxP) while leveraging AI/ML technologies presents unique challenges that require a structured approach. This tutorial aims to guide pharmaceutical professionals through the essential steps…
Model Performance in Edge Cases: A Step-by-Step Guide to AI/ML Model Validation in GxP Analytics As the pharmaceutical industry increasingly adopts artificial intelligence (AI) and machine learning (ML) in Good Automated Manufacturing Practice (GxP) environments, the validation and monitoring of these systems has become crucial. A comprehensive approach to AI/ML model validation ensures compliance with regulations such as 21 CFR…
Dashboards for Model Health: What to Show In the increasing prevalence of artificial intelligence (AI) and machine learning (ML) in pharmaceutical analytics, ensuring compliance and maintaining operational effectiveness is paramount. As organizations endeavor to incorporate AI/ML models into their Good Practice (GxP) environments, establishing a robust framework for model validation, monitoring, and governance is essential. This article serves as a…
Linking Drift Signals to CPV and QMS Linking Drift Signals to CPV and QMS in AI/ML Model Validation Understanding Drift in AI/ML Models Drift refers to the phenomenon where machine learning models experience changes in performance due to shifts in the data distribution over time. In the pharmaceutical industry, such shifts can occur due to variations in input data that…
Post-Approval Changes: Model Variants and SKUs Introduction to AI/ML Model Validation in GxP Analytics The advent of Artificial Intelligence (AI) and Machine Learning (ML) has reshaped analytics in the pharmaceutical industry, particularly in Good Automated Manufacturing Practice (GxP) contexts. As laboratories integrate AI/ML models, ensuring regulatory compliance becomes paramount. This comprehensive guide will navigate through the complexities of AI/ML model…
Periodic Review of Model Health Periodic Review of Model Health in AI/ML Validation In the realm of pharmaceutical development and clinical operations, the emergence of artificial intelligence and machine learning (AI/ML) technologies is reshaping the landscape. However, with the implementation of these technologies comes the imperative need for rigorous validation processes to ensure compliance with Good Automated Manufacturing Practice (GxP)…
Outlier & Novelty Detection in Production: An In-Depth Guide for Pharmaceutical Validation In the rapidly evolving landscape of pharmaceutical development, the integration of artificial intelligence (AI) and machine learning (ML) into laboratory processes has revolutionized data analytics, particularly in Good Practice (GxP) environments. The validation of these models plays a critical role in ensuring compliance with regulatory standards mandated by…
Retraining Pipelines: Governance and Evidence Retraining Pipelines: Governance and Evidence Introduction to AI/ML Model Validation in GxP Analytics The rapid advancement of artificial intelligence (AI) and machine learning (ML) applications in the pharmaceutical and biopharmaceutical sectors has raised unprecedented opportunities for efficiencies and innovations in laboratory practices. However, along with these opportunities come significant regulatory responsibilities. This article provides a…
Human Override and Feedback Loops Human Override and Feedback Loops in AI/ML Model Validation Introduction to AI/ML in GxP Analytics In recent years, artificial intelligence (AI) and machine learning (ML) have gained significant traction in Good Practice (GxP) regulated environments such as laboratories (labs) in the pharmaceutical and biotechnology sectors. The utilization of AI/ML for data analysis and decision-making processes…
Small n/Imbalanced Data: Robust Monitoring The integration of artificial intelligence (AI) and machine learning (ML) in Good Practice (GxP) environments has garnered considerable attention, particularly regarding the validation of models utilizing small n/imbalanced data. Robust monitoring of these models is crucial for ensuring compliance with regulatory standards such as FDA, EMA, and MHRA. This guide details a step-by-step approach to…